Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin (Q28264728)

2

0 references

Yong Li

3

0 references

Li Zheng

4

0 references

Yue Zhou

5

0 references

Haidi Jiang

6

0 references

Tao Ning

7

0 references

Zhuoma Basang

8

0 references

Chunfeng Zhang

9

0 references

Yang Ke

Journal of Biological Chemistry

10

0 references

language of work or name

English

0 references

publication date

20 August 2004

0 references

published in

0 references

volume

279

0 references

issue

34

0 references

page(s)

35664-70

0 references

cites work

The causal relation between human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

The human papillomavirus E6 protein and its contribution to malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Human papillomavirus oncoprotein E6 binds to the C-terminal region of human minichromosome maintenance 7 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Identification and characterization of the tuberous sclerosis gene on chromosome 16

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Identification of the coding sequences responsible for Tsc2-mediated tumor suppression using a transgenic rat system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Tuberous sclerosis gene products in proliferation control

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Akt regulates growth by directly phosphorylating Tsc2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Ribosomal S6 kinase signaling and the control of translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

The identification of a conserved binding motif within human papillomavirus type 16 E6 binding peptides, E6AP and E6BP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Rheb fills a GAP between TSC and TOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Tumour suppressors hamartin and tuberin: intracellular signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

TSC2: filling the GAP in the mTOR signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Rheb is an essential regulator of S6K in controlling cell growth in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

The role of the E6-p53 interaction in the molecular pathogenesis of HPV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

TSC1–TSC2: a complex tale of PKB-mediated S6K regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M403385200

21 January 2018

Identifiers

DOI

10.1074/JBC.M403385200

1 reference

Consolidated OpenCitations Corpus – April 2017

1398044

1398044

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference